Evolus, Inc. (EOLS): Price and Financial Metrics

Evolus, Inc. (EOLS)

Today's Latest Price: $3.66 USD

0.08 (-2.14%)

Updated Nov 24 4:00pm

Add EOLS to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

EOLS Stock Summary

  • Of note is the ratio of Evolus Inc's sales and general administrative expense to its total operating expenses; 98.34% of US stocks have a lower such ratio.
  • Revenue growth over the past 12 months for Evolus Inc comes in at 257.99%, a number that bests 97.38% of the US stocks we're tracking.
  • Evolus Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -84.3%, greater than the shareholder yield of just 4.59% of stocks in our set.
  • Stocks that are quantitatively similar to EOLS, based on their financial statements, market capitalization, and price volatility, are YAYO, MGPI, RIBT, ESNT, and NWPX.
  • Visit EOLS's SEC page to see the company's official filings. To visit the company's web site, go to www.evolus.com.

EOLS Stock Price Chart Interactive Chart >

Price chart for EOLS

EOLS Price/Volume Stats

Current price $3.66 52-week high $14.64
Prev. close $3.74 52-week low $2.85
Day low $3.54 Volume 445,900
Day high $3.75 Avg. volume 731,515
50-day MA $3.74 Dividend yield N/A
200-day MA $4.49 Market Cap 123.52M

Evolus, Inc. (EOLS) Company Bio

Evolus, Inc. provides medical aesthetic products for physicians and their patients in the United States. It offers DWP-450, an injectable 900 kilodalton botulinum toxin type A complex designed to address the needs of the facial aesthetics market. The company was founded in 2012 and is based in Irvine, California.

EOLS Latest News Stream

Event/Time News Detail
Loading, please wait...

EOLS Latest Social Stream

Loading social stream, please wait...

View Full EOLS Social Stream

Latest EOLS News From Around the Web

Below are the latest news stories about Evolus Inc that investors may wish to consider to help them evaluate EOLS as an investment opportunity.

The Daily Biotech Pulse: Legal Relief For Evolus, Fulgent to Join S&P SmallCap 600, AIM ImmunoTech's Positive Cancer Drug Readout

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 21) …

Benzinga | September 22, 2020

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Evolus, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)---- $EOLS #EOLS--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Evolus, Inc.

Business Wire | September 9, 2020

Evolus Inc. (EOLS) CEO David Moatazedi on Q2 2020 Results - Earnings Call Transcript

Evolus, Inc. (EOLS) Q2 2020 Earnings Conference Call August 10, 2020 4:30 PM ET Company Participants Ashwin Agarwal - Vice President, Finance, Investor Relations and Treasury David Moatazedi - President and Chief Executive Officer Mike Jafar - Chief Marketing Officer Rui Avelar - Chief Medical Officer Lauren Silvernail - Chief...

SA Transcripts on Seeking Alpha | August 11, 2020

Evolus, Inc. 2020 Q2 - Results - Earnings Call Presentation

The following slide deck was published by Evolus, Inc. in conjunction with their 2020 Q2 earnings call....

SA Transcripts on Seeking Alpha | August 10, 2020

Earnings Outlook For Evolus

On Monday, August 10, Evolus (NASDAQ: EOLS) will release its latest earnings report. Benzinga's outlook for Evolus is included in the following …

Benzinga | August 7, 2020

Read More 'EOLS' Stories Here

EOLS Price Returns

1-mo 10.24%
3-mo 5.78%
6-mo -19.91%
1-year -73.84%
3-year N/A
5-year N/A
YTD -69.93%
2019 2.27%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Continue Researching EOLS

Want to see what other sources are saying about Evolus Inc's financials and stock price? Try the links below:

Evolus Inc (EOLS) Stock Price | Nasdaq
Evolus Inc (EOLS) Stock Quote, History and News - Yahoo Finance
Evolus Inc (EOLS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8105 seconds.